Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis

Daniel M F Claassens; Thomas O Bergmeijer; Gerrit J A Vos; Renicus S Hermanides; Arnoud W J van 't Hof; Pim van der Harst; Emanuele Barbato; Carmine Morisco; Richard M Tjon Joe Gin; Folkert W Asselbergs; Arend Mosterd; Jean-Paul R Herrman; Willem J M Dewilde; Paul W A Janssen; Johannes C Kelder; Bakhtawar K Mahmoodi; Vera H M Deneer; Jurriën M Ten Berg

doi:https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis

Daniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, Renicus S Hermanides, Arnoud W J van 't Hof, Pim van der Harst, Emanuele Barbato, Carmine Morisco, Richard M Tjon Joe Gin, Folkert W Asselbergs, Arend Mosterd, Jean-Paul R Herrman, Willem J M Dewilde, Paul W A Janssen, Johannes C Kelder, Bakhtawar K Mahmoodi, Vera H M Deneer, Jurriën M Ten Berg

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

[Figure: see text].

Original language	English
Pages (from-to)	e009434
Journal	Circulation. Cardiovascular interventions
Volume	14
Issue number	4
DOIs	https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434
Publication status	Published - Apr 2021
Externally published	Yes

Keywords

Acute Coronary Syndrome/drug therapy
Clopidogrel/adverse effects
Cytochrome P-450 CYP2C19/genetics
Genotype
Humans
Percutaneous Coronary Intervention/adverse effects
Platelet Aggregation Inhibitors/adverse effects
Prasugrel Hydrochloride/adverse effects
Ticagrelor/adverse effects
Treatment Outcome

Access to Document

https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

Cite this

Claassens, D. M. F., Bergmeijer, T. O., Vos, G. J. A., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., Barbato, E., Morisco, C., Tjon Joe Gin, R. M., Asselbergs, F. W., Mosterd, A., Herrman, J.-P. R., Dewilde, W. J. M., Janssen, P. W. A., Kelder, J. C., Mahmoodi, B. K., Deneer, V. H. M., & Ten Berg, J. M. (2021). Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. Circulation. Cardiovascular interventions, 14(4), e009434. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

@article{aebe33d3be704f3f948d662c541b6222,

title = "Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis",

abstract = "[Figure: see text].",

keywords = "Acute Coronary Syndrome/drug therapy, Clopidogrel/adverse effects, Cytochrome P-450 CYP2C19/genetics, Genotype, Humans, Percutaneous Coronary Intervention/adverse effects, Platelet Aggregation Inhibitors/adverse effects, Prasugrel Hydrochloride/adverse effects, Ticagrelor/adverse effects, Treatment Outcome",

author = "Claassens, {Daniel M F} and Bergmeijer, {Thomas O} and Vos, {Gerrit J A} and Hermanides, {Renicus S} and {van 't Hof}, {Arnoud W J} and {van der Harst}, Pim and Emanuele Barbato and Carmine Morisco and {Tjon Joe Gin}, {Richard M} and Asselbergs, {Folkert W} and Arend Mosterd and Herrman, {Jean-Paul R} and Dewilde, {Willem J M} and Janssen, {Paul W A} and Kelder, {Johannes C} and Mahmoodi, {Bakhtawar K} and Deneer, {Vera H M} and {Ten Berg}, {Jurri{\"e}n M}",

year = "2021",

month = apr,

doi = "https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434",

language = "English",

volume = "14",

pages = "e009434",

journal = "Circulation. Cardiovascular interventions",

issn = "1941-7640",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

Claassens, DMF, Bergmeijer, TO, Vos, GJA, Hermanides, RS, van 't Hof, AWJ, van der Harst, P, Barbato, E, Morisco, C, Tjon Joe Gin, RM, Asselbergs, FW, Mosterd, A, Herrman, J-PR, Dewilde, WJM, Janssen, PWA, Kelder, JC, Mahmoodi, BK, Deneer, VHM & Ten Berg, JM 2021, 'Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis', Circulation. Cardiovascular interventions, vol. 14, no. 4, pp. e009434. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. / Claassens, Daniel M F; Bergmeijer, Thomas O; Vos, Gerrit J A et al.
In: Circulation. Cardiovascular interventions, Vol. 14, No. 4, 04.2021, p. e009434.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype

T2 - A POPular Genetics Subanalysis

AU - Claassens, Daniel M F

AU - Bergmeijer, Thomas O

AU - Vos, Gerrit J A

AU - Hermanides, Renicus S

AU - van 't Hof, Arnoud W J

AU - van der Harst, Pim

AU - Barbato, Emanuele

AU - Morisco, Carmine

AU - Tjon Joe Gin, Richard M

AU - Asselbergs, Folkert W

AU - Mosterd, Arend

AU - Herrman, Jean-Paul R

AU - Dewilde, Willem J M

AU - Janssen, Paul W A

AU - Kelder, Johannes C

AU - Mahmoodi, Bakhtawar K

AU - Deneer, Vera H M

AU - Ten Berg, Jurriën M

PY - 2021/4

Y1 - 2021/4

N2 - [Figure: see text].

AB - [Figure: see text].

KW - Acute Coronary Syndrome/drug therapy

KW - Clopidogrel/adverse effects

KW - Cytochrome P-450 CYP2C19/genetics

KW - Genotype

KW - Humans

KW - Percutaneous Coronary Intervention/adverse effects

KW - Platelet Aggregation Inhibitors/adverse effects

KW - Prasugrel Hydrochloride/adverse effects

KW - Ticagrelor/adverse effects

KW - Treatment Outcome

U2 - https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

DO - https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434

M3 - Article

C2 - 33722066

SN - 1941-7640

VL - 14

SP - e009434

JO - Circulation. Cardiovascular interventions

JF - Circulation. Cardiovascular interventions

IS - 4

ER -

Claassens DMF, Bergmeijer TO, Vos GJA, Hermanides RS, van 't Hof AWJ, van der Harst P et al. Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis. Circulation. Cardiovascular interventions. 2021 Apr;14(4):e009434. doi: https://doi.org/10.1161/CIRCINTERVENTIONS.120.009434